OptiNose News

OptiNose Analyst Ratings

BenzingaMay 15 11:12 ET

Analysts Are Bullish on These Healthcare Stocks: ScPharmaceuticals (SCPH), Optinose (OPTN)

TipRanksMay 15 09:01 ET

Optinose's XHANCE Expansion Drives Buy Rating Amidst Growth Potential

TipRanksMay 15 06:28 ET

Lake Street Reaffirms Their Buy Rating on Optinose (OPTN)

TipRanksMay 9 08:58 ET

Analysts' Top Healthcare Picks: Longeveron (LGVN), Optinose (OPTN)

TipRanksApr 29 06:20 ET

OptiNose Analyst Ratings

BenzingaApr 29 06:17 ET

Lake Street Remains a Buy on Optinose (OPTN)

TipRanksMar 26 08:45 ET

Lake Street Sticks to Their Buy Rating for Optinose (OPTN)

TipRanksMar 18 08:45 ET

Analysts' Top Healthcare Picks: Soleno Therapeutics (SLNO), Optinose (OPTN)

TipRanksMar 18 07:00 ET

OptiNose Analyst Ratings

BenzingaMar 18 06:55 ET

OptiNose Analyst Ratings

BenzingaMar 11 07:10 ET

Analysts Offer Insights on Healthcare Companies: Joint (JYNT), IGM Biosciences (IGMS) and Optinose (OPTN)

TipRanksMar 8 09:01 ET

Piper Sandler Reaffirms Their Buy Rating on Optinose (OPTN)

TipRanksNov 10, 2023 10:18 ET

Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), Optinose (OPTN)

TipRanksOct 11, 2023 09:20 ET

Lake Street Initiates Coverage On OptiNose With Buy Rating, Announces Price Target of $3

BenzingaAug 21, 2023 09:15 ET

OptiNose Analyst Ratings

BenzingaAug 21, 2023 09:04 ET

OptiNose Analyst Ratings

BenzingaAug 11, 2023 12:31 ET

Optinose (OPTN) Receives a Buy From Piper Sandler

TipRanksAug 11, 2023 09:16 ET

Optinose (OPTN) Gets a Buy From BMO Capital

TipRanksFeb 1, 2023 09:10 ET

BMO Capital Adjusts Price Target on OptiNose to $5 From $6, Maintains Outperform Rating

MT NewswiresNov 14, 2022 09:45 ET